Recent Comments
- Ryan Matthews on The Weekly Summary
- Pablo C. Narido on Are there any medications to treat coronavirus?
- William Schaffner, MD on Are there any medications to treat coronavirus?
- M on The problem of erroneous diagnoses never falling off the chart
- Denis Donovan, MD on Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital.
Most Viewed Posts
- The Healthcare Channel hits 10 (4,842)
- How the FDA regulates compounding pharmacies (4,308)
- The new CDC guidelines for prescribing opioid pain pills (3,460)
- Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital. (3,023)
- The Who’s Teen Cancer Lounge at Sloan Kettering opens (2,838)
- The MusiCorps benefit concert 2015 (2,361)
- President Trump adopts plan by The Healthcare Channel to bring back drug manufacturing jobs (2,138)
- Victory for America (2,128)
- Daily aspirin once again proves to be of no use and also deadly (1,993)
- Insurance companies are not paying for Repatha and Praluent (1,802)
Pages
Categories
- – Biotech
- – Generics
- – JAMA
- – Medical Devices
- – NEJM
- – Opinion
- – Pharma
- – Policy
- – Reviews, books, devices
- – The Weekly Summary
- Bariatric surgery
- Cardiac surgery
- Cardiology
- Dermatology
- Diabetes and endocrinology
- Emergency medicine
- Gastroenterology and liver
- General surgery
- Genetics
- Geriatrics
- Infectious disease
- Internal Medicine
- Neurology
- Neurosurgery
- Obstetrics and Gynecology
- Oncology
- Ophthalmology
- Orthopedic surgery
- Pediatrics
- Plastic surgery
- Primary care medicine
- Psychology Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Spine surgery
- Sports medicine
- Transplant surgery
- Trauma Surgery
- Uncategorized
- Urology
- Vascular Surgery
- Z Medical centers
- Baylor
- Boston University
- Cedars Sinai
- Cleveland Clinic
- Columbia
- Cornell
- Duke
- Emory
- George Washington Univ
- Harvard
- Henry Ford
- Iowa State
- Johns Hopkins
- Mayo Clinic
- McMaster University
- Medical University of South Carolina
- Memorial Sloan-Kettering
- Michigan
- National Jewish Health
- NYU
- Ohio State
- Oregon Health and Science University
- UC Davis
- UC San Francisco
- UCLA
- Univ Kentucky
- Univ Maryland
- Univ Miami
- Univ Michigan
- Univ of Louisville
- Univ Texas
- VA Walter Reed
- Vanderbilt
- VCU
- Washington University
- Yale
Category Archives: McMaster University
Early stoppage of clinical trials
April 16, 2009– Dr. Guyatt explained in a previous post why early stoppage of clinical trials results
Posted in Cardiac surgery, FDA, McMaster University
Leave a comment
Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs
October 24, 2010- Gordon Guyatt, MD, epidemiologist, internist, and biostatistician at McMaster
Posted in Cardiology, FDA, McMaster University
Leave a comment
Gordon Guyatt, MD: on the problem of early stoppage of clinical trials
January 7, 2009- The ARBITER 6-HALTS study investigating Zetia and Niaspan was stopped
Posted in Cardiology, FDA, McMaster University
Leave a comment